{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Portage Biotech, Inc.
Is Portage Biotech, Inc. technically bullish or bearish?
As of June 9, 2025, Portage Biotech, Inc. shows a mildly bullish trend due to daily moving averages, but caution is advised as weekly indicators are bearish and Bollinger Bands reflect mixed signals.
What does Portage Biotech, Inc. do?
Portage Biotech, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $1 million and a market cap of $6.43 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -386.34%.
How big is Portage Biotech, Inc.?
As of Jun 18, Portage Biotech, Inc. has a market capitalization of 6.43 million and reported net sales of 0.00 million, with a net profit of -67.31 million over the last four quarters. The balance sheet shows shareholder's funds of 4.02 million and total assets of 7.78 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
